isoproterenol has been researched along with quercetin in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.26) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 3 (15.79) | 29.6817 |
| 2010's | 13 (68.42) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barrett, KE; Metcalfe, DD; Szucs, EF | 1 |
| Morita, T; Motoyashiki, T; Ueki, H | 1 |
| Carpéné, C; Marti, L; Prévot, D; Visentin, V | 1 |
| Prince, PS; Punithavathi, VR | 2 |
| Prince, PS; Sathya, B | 1 |
| Ahokas, RA; Bhattacharya, SK; Gerling, IC; Johnson, PL; Shahbaz, AU; Sun, Y; Weber, KT; Zhao, T; Zhao, W | 1 |
| Banerjee, T; Kar, A; Panda, S; Sharma, N | 1 |
| Liu, H; Lu, S; Zhang, L | 1 |
| Aydinoglu, F; Ertuğ, PU; Goruroglu Ozturk, O; Ögülener, N; Singirik, E | 1 |
| Emala, CW; Townsend, EA | 1 |
| Jiang, Y; Jing, W; Li, M; Miao, C; Ren, L; Sun, B | 1 |
| Adaramoye, OA; Lawal, SO | 1 |
| Filipský, T; Holečková, M; Hrdina, R; Mladěnka, P; Nováková, L; Palicka, V; Pilařová, V; Ríha, M; Semecký, V; Vávrová, J; Vopršalová, M | 1 |
| Kar, A; Panda, S | 1 |
| Bodduluru, LN; Kasala, ER; Kumar, M; Kumar, V; Lahkar, M | 1 |
| Hayamizu, K; Hoka, S; Morimoto, S; Nonaka, M; Sasaguri, T | 1 |
| Cui, X; Hu, J; Kuang, W; Li, D; Wang, J; Wang, X | 1 |
19 other study(ies) available for isoproterenol and quercetin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Mast cell heterogeneity in higher animals: a comparison of the properties of autologous lung and intestinal mast cells from nonhuman primates.
Topics: Animals; Bucladesine; Haplorhini; Histamine Release; Immunoglobulin E; Intestines; Isoproterenol; Lung; Mast Cells; Quercetin; SRS-A; Staining and Labeling; Substance P; Theophylline | 1986 |
Involvement of the rapid increase in cAMP content in the vanadate-stimulated release of lipoprotein lipase activity from rat fat pads.
Topics: Adipose Tissue; Animals; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Enzyme Activation; Isoproterenol; Lipoprotein Lipase; Male; Propranolol; Quercetin; Rats; Rats, Wistar; Vanadates | 1996 |
Inhibition of rat fat cell lipolysis by monoamine oxidase and semicarbazide-sensitive amine oxidase substrates.
Topics: Adipocytes; Amine Oxidase (Copper-Containing); Androstadienes; Animals; Benzylamines; Cells, Cultured; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Glutathione; Hydrogen Peroxide; Insulin; Isoproterenol; Lipolysis; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Oxidation-Reduction; Pargyline; Phosphoinositide-3 Kinase Inhibitors; Quercetin; Rats; Rats, Wistar; Substrate Specificity; Tyramine; Vanadates; Wortmannin | 2003 |
Combined effects of quercetin and alpha-tocopherol on lipids and glycoprotein components in isoproterenol induced myocardial infarcted Wistar rats.
Topics: alpha-Tocopherol; Animals; Glycoproteins; Isoproterenol; Lipid Metabolism; Male; Myocardial Infarction; Quercetin; Rats; Rats, Wistar | 2009 |
Pretreatment with a combination of quercetin and alpha-tocopherol ameliorates adenosine triphosphatases and lysosomal enzymes in myocardial infarcted rats.
Topics: Adenosine Triphosphatases; alpha-Tocopherol; Animals; Antioxidants; Ca(2+) Mg(2+)-ATPase; Cell Membrane; Disease Models, Animal; Drug Therapy, Combination; Isoproterenol; Lipid Peroxidation; Lysosomes; Male; Myocardial Infarction; Myocardium; Pilot Projects; Quercetin; Rats; Rats, Wistar; Sodium-Potassium-Exchanging ATPase | 2010 |
Pretreatment with quercetin ameliorates lipids, lipoproteins and marker enzymes of lipid metabolism in isoproterenol treated cardiotoxic male Wistar rats.
Topics: Animals; Biomarkers; Cardiotoxins; Electrocardiography; Enzymes; Free Radical Scavengers; Heart; Isoproterenol; Lipid Metabolism; Lipoproteins; Liver; Male; Myocardium; Quercetin; Rats; Rats, Wistar | 2010 |
Calcium and zinc dyshomeostasis during isoproterenol-induced acute stressor state.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Antioxidants; Calcium; Capillary Permeability; Carbazoles; Carvedilol; Endothelium; Homeostasis; In Vitro Techniques; Isoproterenol; Male; Metallothionein; Mitochondria, Heart; Myocardium; Myocytes, Cardiac; Necrosis; Oxidative Stress; Propanolamines; Quercetin; Rats; Rats, Sprague-Dawley; Sarcolemma; Stress, Physiological; Superoxide Dismutase; Zinc | 2011 |
Combined effects of quercetin and atenolol in reducing isoproterenol-induced cardiotoxicity in rats: possible mediation through scavenging free radicals.
Topics: Administration, Oral; Adrenergic beta-Agonists; Animals; Antihypertensive Agents; Atenolol; Cardiotonic Agents; Disease Models, Animal; Drug Therapy, Combination; Enzymes; Free Radical Scavengers; Heart; Injections, Subcutaneous; Isoproterenol; Myocardium; Necrosis; Quercetin; Rats; Rats, Wistar | 2012 |
Evaluation of antioxidant and immunity activities of quercetin in isoproterenol-treated rats.
Topics: Animals; Antioxidants; Ca(2+) Mg(2+)-ATPase; Creatine Kinase, MB Form; Cytokines; Electrocardiography; Glutathione; Heart; Immunologic Factors; Isoproterenol; Lactate Dehydrogenases; Myocardial Ischemia; Myocardium; Nitric Oxide Synthase; Oxidative Stress; Quercetin; Rats; Rats, Wistar; Sodium-Potassium-Exchanging ATPase; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2012 |
Comparative study of the quercetin, ascorbic acid, glutathione and superoxide dismutase for nitric oxide protecting effects in mouse gastric fundus.
Topics: Aminoquinolines; Animals; Antioxidants; Ascorbic Acid; Ditiocarb; Female; Gastric Fundus; Glutathione; In Vitro Techniques; Isoproterenol; Male; Mice; Muscle Relaxation; Nitric Oxide; Oxidants; Oxidative Stress; Pyrogallol; Quercetin; Superoxide Dismutase | 2013 |
Quercetin acutely relaxes airway smooth muscle and potentiates β-agonist-induced relaxation via dual phosphodiesterase inhibition of PLCβ and PDE4.
Topics: Acetylcholine; Adrenergic beta-Agonists; Airway Resistance; Animals; Antioxidants; Blotting, Western; Bronchoconstrictor Agents; Calcium; Cells, Cultured; Cholinergic Agonists; Cyclic Nucleotide Phosphodiesterases, Type 4; Humans; Inositol Phosphates; Isoproterenol; Male; Methacholine Chloride; Mice; Mice, Inbred A; Muscle Relaxation; Myocytes, Smooth Muscle; Nitric Oxide; Phosphodiesterase 4 Inhibitors; Phospholipase C beta; Prostaglandins; Quercetin; Respiratory System; Type C Phospholipases | 2013 |
Quercetin provides greater cardioprotective effect than its glycoside derivative rutin on isoproterenol-induced cardiac fibrosis in the rat.
Topics: Adrenergic beta-Agonists; Animals; Antioxidants; Blotting, Western; Cardiotonic Agents; Endomyocardial Fibrosis; Extracellular Matrix; Glycosides; Heart Function Tests; Hemodynamics; Immunohistochemistry; Isoproterenol; Male; Myocardium; Organ Size; Quercetin; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Renin-Angiotensin System; Rutin; Transforming Growth Factor beta | 2013 |
Kolaviron, a biflavonoid fraction from Garcinia kola, protects against isoproterenol-induced injury by mitigating cardiac dysfunction and oxidative stress in rats.
Topics: Animals; Antioxidants; Cardiotonic Agents; Cardiotoxicity; Dose-Response Relationship, Drug; Flavonoids; Garcinia kola; Isoproterenol; Male; Oxidative Stress; Quercetin; Rats; Rats, Wistar; Seeds | 2015 |
Oral administration of quercetin is unable to protect against isoproterenol cardiotoxicity.
Topics: Administration, Oral; Animals; Aorta, Thoracic; Cardiotoxicity; Hemodynamics; Isoproterenol; Male; Myocardium; Quercetin; Rats; Troponin T | 2014 |
Combined Effects of Vincristine and Quercetin in Reducing Isoproterenol-Induced Cardiac Necrosis in Rats.
Topics: Animals; Antioxidants; Biomarkers; Cardiomyopathies; Cytoprotection; Disease Models, Animal; Drug Therapy, Combination; Electrocardiography; Heart Rate; Isoproterenol; Lipid Peroxidation; Male; Myocytes, Cardiac; Necrosis; Oxidative Stress; Quercetin; Rats, Wistar; Vincristine | 2015 |
Molecular and biochemical evidence on the protective effects of quercetin in isoproterenol-induced acute myocardial injury in rats.
Topics: Animals; Calpain; Cardiotonic Agents; Gene Expression Regulation, Enzymologic; Isoproterenol; Male; Myocardial Infarction; Myocardium; Oxidative Stress; Quercetin; Rats; Rats, Wistar | 2017 |
Cardiotonic actions of quercetin and its metabolite tamarixetin through a digitalis-like enhancement of Ca
Topics: Animals; Calcium Signaling; Cardiotonic Agents; Digitalis Glycosides; Digoxin; Disaccharides; In Vitro Techniques; Isoproterenol; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocardial Contraction; Myocytes, Cardiac; Quercetin | 2018 |
Quercetin prevents isoprenaline-induced myocardial fibrosis by promoting autophagy via regulating miR-223-3p/FOXO3.
Topics: Animals; Atrial Fibrillation; Atrial Remodeling; Autophagy; Autophagy-Related Proteins; Case-Control Studies; Cell Cycle Proteins; Cell Proliferation; Disease Models, Animal; Fibrosis; Forkhead Box Protein O3; Heart Atria; HEK293 Cells; Humans; Isoproterenol; MicroRNAs; Quercetin; Rats, Wistar; Signal Transduction | 2021 |